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Abstract
Coronavirus disease (COVID-19), caused by a highly contagious novel coronavirus, has seen a rapid surge of cases 
over the past 6 months spreading to more than 215 countries and posing a global threat to mankind. Reverse trans-
criptase-polymerase chain reaction (RT-PCR) from pharyngeal swabs is considered the gold standard for diagnosis of 
this disease. Portable chest radiography (CXR), point of care ultrasound, and computed tomography (CT) are crucial 
modalities in diagnosis and follow-up. Portable CXR can help in patients who are clinically unstable, and also to pre-
vent the cumbersome process of steriliastion after every CT scan. However, chest CT is useful as a problem-solving 
tool, to look for progression and complications associated with the disease. In a few cases, in our experience (as has 
also been documented by others), RT-PCR was negative in early disease, and CT chest was able to detect the radiologi-
cal findings raising suspicion of COVID-19. With this pictorial review, we aim to describe and illustrate the typical, 
and a few atypical, radiological findings of this disease.
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Introduction
Coronavirus disease 2019 (COVID-19), an on-going 
pandemic caused by severe acute respiratory syndrome 
coronavirus 2 (SARS-CoV-2), was reported for the first 
time in Wuhan city of Hubei province in China in Decem-
ber 2019. It has since spread rapidly to other parts of the 
world, causing a great deal of economic, social, historic, 
and scientific impact [1]. The World Health Organisa-
tion (WHO) declared the outbreak a global public health 
emergency on January 30th, 2020.
The clinical symptoms of COVID-19 can range from 
asymptomatic to mild disease (generalised body ache, dry 
cough, fever, and nasal congestion). The severe form of 
the disease is characterised by hypoxaemia, septic shock, 
coagulopathy, metabolic abnormalities, and death [2]. 
Altered sense of smell or taste in mild stages of the dis-
ease has also been observed [3]. Laboratory abnormalities 
include leucopaenia, elevated levels of serum ferritin, al-
tered liver function tests, and raised cytokine levels (IL-6, 
IL-10). Evidence shows that a cytokine storm is induced 
by the virus by over-activation of the T cells, which causes 
lung damage leading to acute lung injury (ALI) [4]. 
The diagnosis of COVID-19 pneumonia is made by 
the detection of viral nucleic acid in pharyngeal swabs, 
sputum, or blood. The specificity of this test is high, with 
low sensitivity, due to which few patients show false 
negative results [5]. Studies have shown that radiological 
findings are observed earlier than the symptoms, which 
makes imaging important for early diagnosis and timely 
isolation [6]. This pictorial review aims to highlight the 
chest radiography (CXR) and computed tomography (CT) 
patterns of lung abnormality and common manifestations 
of COVID-19 pneumonia. A brief mention of point-of-
care ultrasound (POCUS) has also been made. An aware-
ness of these features will better equip radiologists in mak-
ing an early and appropriate diagnosis.
Imaging in COVID-19
CXR and CT form the mainstay for imaging diagnosis of 
COVID-19 pneumonia. 
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Chest radiographs
CXR have a vital role to play in COVID-19 pneumonia, 
considering its highly contagious nature. Due to infection 
control issues and the requirement of effective decontami-
nation of CT suites after scanning every patient, CT may 
not be possible for all patients. Furthermore, CXR is more 
readily available, inexpensive, and is the initial modality 
for screening [7]. In severe disease with acute respiratory 
distress syndrome (ARDS), portable CXRs are of para-
mount importance because patients cannot be mobilised 
for CT. A few specific patterns of disease have been ob-
served, which are described below.
Ground-glass opacities
Ground-glass opacities are the earliest and the most com-
mon imaging manifestation of COVID-19 pneumonia; 
however, CXR has a low sensitivity for detection (69%) [8]. 
They become more conspicuous when an accompanying 
reticular pattern is present. 
Peripheral alveolar opacities (Figure 1)
The predilection of COVID-19 to affect the peripheral 
lung fields is what makes it unique from other types of 
pneumonia. These peripheral opacities may be patchy or 
confluent and can be picked up on chest radiographs [9]. 
The opacities in COVID-19 pneumonia are often bilat-
eral and multifocal, as compared to bacterial pneumonia, 
which is often unilateral and limited to a single lobe [7].
Lower lobe predominant consolidation (Figure 2)
COVID-19 and other viral pneumonias typically pres-
ent as lung opacities involving more than one lobe with 
a propensity for lower lung involvement [7,9]. A unilat-
eral, central, or upper lobe predominant distribution is 
suspicious but indeterminate for COVID-19 infection and 
can also be seen in a variety of other infectious and non-
infectious conditions.
Multifocal and diffuse air space opacities (Figures 3 and 4)
Diffuse air space opacities in COVID-19 are similar to the 
ARDS-like diffuse process that is seen with other wide-
spread pulmonary infections. Most patients with these 
patterns are severely hypoxic and are usually intubated 
or on mechanical ventilation. The appearance is that of 
multifocal diffuse alveolar opacities in both lung fields 
and is usually seen in the late first or early second week of 
clinical symptoms [7]. 
Figure 1. Peripheral predominant pattern of COVID-19 pneumonia. A) Schematic diagram depicting a peripheral predominant pattern of disease. 
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Figure 2. Lower lobe predominant pattern of COVID-19 pneumonia. A) Schematic diagram depicting a lower lobe predominant pattern of disease. 







Figure 3. Multifocal pattern of COVID-19 pneumonia. A) Schematic diagram depicting a multifocal pattern of disease. B-D) Frontal chest radiography 
of 3 different patients with COVID-19 show areas of patchy alveolar opacities distributed in both lung fields (red asterisks)
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A caveat to this is that a normal CXR is not uncom-
mon in an asymptomatic individual or those presenting 
early in the course of the disease. Hence, the role of CT 
scan of the chest in COVID-19 infection is indispensable. 
In our experience, few patients had imaging findings of 
COVID-19 with an initial negative swab, as illustrated in 
Figure 5.
Point-of-care ultrasound
Ultrasound (US), being a readily available and dynamic 
modality, is relevant in the imaging of COVID-19 pneu-
monia. Due to the high contagiousness of the disease and 
inability to transport unstable patients from the intensive 
care unit, CT may present as a limited option. In these 
settings, POCUS may provide results similar to CT and 
superior to radiographs in evaluation and follow-up [10].
US is performed by placing curvilinear or linear high-
frequency transducers along the intercostal spaces. On 
US, findings such as thickening of the pleural line, B lines 
(appearing as multiple hyperechoic laser-like reverbera-
tion artefacts extending from the pleural line to the base 
of the screen without fading), and hypoechoic lung with 
air bronchograms due to alveolar consolidation have been 
described in cases of COVID-19 pneumonia [10,11]. Few 
such findings are demonstrated in Figure 6. 
Computed tomography
SARS CoV-2 utilises the angiotensin-converting enzyme-2 
(ACE-2) receptors in humans and causes damage to the 
pulmonary interstitium and subsequently the parenchyma 
[12]. Although a pharyngeal swab test is the standard as-
sessment for 2019-nCoV infection diagnosis, current tests 
are time-consuming and may not be easily available due 
to the high demand. Sampling errors or insufficient vi-
ral material in the specimen may also be responsible for 
a false negative test result. 
The critical role of CT in the early detection of patients 
with COVID-19 infection has modified treatment proto-
cols in many parts of the world. Non-contrast CT obtained 
in the supine position with breath-hold to minimise mo-
tion artifacts is the standard protocol in many institutes for 
diagnosis of COVID-19 infection [13]. At our institution, 
high-resolution computed tomography (HRCT) scans were 
performed with all patients in the supine position at end 
inspiration. Use of intravenous contrast was limited to pa-
tients with suspected pulmonary thromboembolism and 
raised D-dimer levels. All images were reconstructed at 
1.0 mm slice thickness with 1 mm increment, 512 mm 
× 512 mm, and a sharp reconstruction kernel. 
Various CT appearances of COVID-19 have been de-




Figure 4. Diffuse pattern of COVID-19 pneumonia. A) Schematic diagram depicting a diffuse pattern of disease. B-D) Frontal chest radiography of 3 different 
patients with clinical diagnosis of acute respiratory distress syndrome due to COVID-19 show varying degrees of parenchymal opacification in both lung fields
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Figure 5. A 50-year-old man with COVID-19 pneumonia came with high-grade fever and loss of appetite for 2 days. The initial nasopharyngeal swab was 
negative for SARS-CoV-2. However, (A) frontal chest radiography on day 1 of presentation shows subtle ill-defined patchy opacity in the right lower zone 
(red arrow). B) Coronal reformatted computed tomography chest image shows a peripheral area of ground-glass opacity with interlobular septal thickening 





Figure 6. Ultrasound (US) findings in COVID-19 pneumonia. A) Grey-scale US image of the normal lung using a linear array transducer shows a continuous thin 
pleural line (yellow arrowhead) with multiple reverberation artefacts parallel to it – A lines (red arrowhead). B) A 54-year-old man with COVID-19 pneumonia. 
US performed using a curvilinear array transducer shows multiple laser-like hyperechoic lines erasing the A lines – B lines (red arrows). C) Confluent B-lines in the 
same patient as (B) – Waterfall sign (red asterisk). D) A 62-year-old woman with COVID-19 pneumonia. US performed using a linear array transducer showing 
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detail. The “Expert Recommendations from the Chinese 
Medical Association Radiology Branch” divides the CT 
manifestations of COVID-19 into three stages: early, ad-
vanced, and severe, based on the extent of lung involve-
ment with an additional dissipation stage [14].
Early stage (0-4 days)
Ground-glass opacity (GGO) (Figures 7 and 8) is defined 
as increased lung opacity that does not obscure the vascu-
lar margins. It is caused by partial filling of air spaces with 
fluid, pus, or blood and resultant displacement of air [15]. 
The occurrence of multifocal unilateral or bilateral rounded 
GGOs in the periphery of the lung fields with a subpleu-
ral predominance is a common finding in patients with 
COVID-19 pneumonia. Multiple studies have confirmed 
these findings with accompanying features of interlobular 
septal thickening, fibrosis, and consolidation [16,17].
Vascular enlargement (Figure 9) is the dilatation of 
the pulmonary vasculature within or around the lesions 
Figure 7. Distribution of ground-glass opacities on axial sections of high-resolution computed tomography chest in 2 different patients with COVID-19 
pneumonia. A) A 37-year-old man, 3 days after symptom onset – subtle GGOs in the periphery of both lung fields (red arrows). B) A 49-year-old man, 
5 days after symptom onset – multifocal GGOs (red arrows) with vascular thickening (yellow arrowhead) in both lung fields
Figure 8. Axial high-resolution computed tomography (HRCT) chest images. A) Confluent ground-glass opacities with a peripheral and subpleural distri-
bution in both lung fields (red asterisks) in a 47-year-old woman with significant hypoxia. B) A 52-year-old man presented to the emergency room with 
breathlessness and poor oxygen saturation for three days. Axial HRCT image shows extensive, diffuse GGOs in both lung fields (red arrows) with few areas 





Figure 9. A) Coned down axial high-resolution computed tomography chest image of a patient with COVID-19 shows rounded ground-glass opacity (GGO) in 
the right upper lobe (red arrow). B) Coned down axial computed tomography image in a different patient shows vascular thickening (red arrow), in a background 
of interlobular septal thickening with GGOs (crazy paving appearance). The normal calibre of a peripheral vessel is shown for comparison (yellow arrow)
A B
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Figure 10. Axial thin sections of chest high-resolution computed tomography (HRCT) of patients with COVID-19 pneumonia in first and the second week of 
symptoms. A) A 50-year-old man with ground-glass opacities (GGOs) and interlobular septal thickening giving a crazy paving appearance in the superior 
segment of the right lower lobe (red arrowheads). B) Coned down axial HRCT chest image shows patchy consolidation with a traversing patent bronchus – air 
bronchogram (red arrowheads) in the left lower lobe of a 26-year-old female presenting with high-grade fever. The surrounding GGO gives the appearance 
of a halo (halo sign). This is better depicted in (C) obtained at another level (red arrowheads). D) A 37-year-old female with COVID-19 pneumonia. HRCT 
chest obtained 9 days after symptom onset, shows perilobular consolidation (red arrowheads) with reticular densities in both upper lobes giving rise to 
a reverse halo – atoll sign (red arrow). E) Lower sections of the chest in the same patient as (D) shows ill-defined GGOs in the posterobasal segment of the 
right lower lobe (red arrow) with adjacent pleural thickening (red arrowheads). F) Bronchial wall thickening (red arrowhead) in a 40-year-old male. Note 




seen on CT. This manifestation may be due to endothelial 
damage to the capillary walls resulting from inflammatory 
mediator release.
Advanced stage (5-8 days) (Figure 10)
Chest CT in this stage shows new focal lesions with an 
increase in the density of the previous GGOs, resulting in 
consolidations with air bronchograms. 
Crazy paving pattern (Figure 10A): Thickening of the 
interlobular septa with superimposed GGOs is known as 
crazy paving appearance, similar to the irregular pave-
ment stones. This finding is relatively rare in COVID-19 
pneumonia and results from alveolar oedema with super-
imposed interstitial inflammation [15]. The appearance of 
crazy paving on CT along with diffuse GGOs and consoli-
dations may be an indication of the disease entering the 
progressive stage [18].
Consolidation (Figure 10B): When the alveolar air is 
replaced by blood, fluid, or tissue, the result is an increase 
in the parenchymal opacity that obscures the vascular 
margins and the airway walls [15]. Multifocal bilateral 
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patchy consolidations with a peripheral and subpleural 
predominance in a peribronchovascular distribution is 
another common presentation of COVID-19 pneumonia. 
It is thought to occur due to cellular and fibro-myxoid 
exudates within the alveoli [19]. The role of positron emis-
sion tomography/ computed tomography (PET/CT) in 
COVID-19 pneumonia has been sparsely documented in 
the published literature with few reports of 18-fluoro-de-
oxy-glucose (FDG) avidity within the consolidations and 
associated mediastinal lymph nodes, similar to Middle 
East respiratory syndrome (MERS) or H1N1 influenza 
virus [20,21]. 
Halo and reverse halo signs (Figure 10C-D): Halo 
sign refers to nodules surrounded by GGO [15]. This sign 
is seen in hyper-vascular metastasis and angio-invasive 
fungal infections due to perilesional haemorrhage. It has 
also been described in atypical infections and organising 
pneumonia [22], the pathophysiology of which is unclear.
The reverse halo or atoll sign is defined as a focal round-
ed GGO or normal lung parenchyma surrounded by a ring 
of consolidation [15]. 
Pleural changes (Figure 10E): Pleural thickening and 
pleural effusion have rarely been reported in the disease, 
with pleural thickening being relatively more common [23]. 
The appearance of pleural effusion may suggest a poorer 
prognosis in COVID-19, similar to the findings in the 
Middle East respiratory syndrome corona virus (MERS-
CoV) [23].
Airway changes (Figure 10F): Bronchiectasis and 
bronchial wall thickening have been reported in multiple 
cases; these findings are likely to be due to inflammatory 
damage to the bronchial walls followed by fibrosis, scar-
ring, and resultant traction bronchiectasis [17,24]. 
Air bubble sign (Figure 11): A section through an 
area of bronchiolectasis or partial resorption of consolida-
tion may give rise to central lucencies, which are referred 
to as air bubble sign [23].
Severe stage (9-13 days) (Figure 12B)
This stage shows diffuse multifocal consolidations with air 
bronchograms and bronchial dilatation. 
Dissipation stage (≥ 14 days) (Figure 13)
This stage is seen most commonly after two weeks and 
is characterised by gradual resolution of the GGOs and 
consolidations with residual fibrosis and curvilinear lines.
Figure 12. A 38-year-old diabetic female presented with two days of cough, fever, and breathlessness. A) Initial high-resolution computed tomography chest 
shows subtle ground-glass opacities (GGOs) in both lower lobes (red arrows). However, her condition in the ward worsened over the next 10 days. A repeat 
scan (B) shows multifocal dense GGOs with forming consolidations in both lung fields suggestive of severe stage of COVID-19 pneumonia
A B
Figure 11. Rounded lucencies within an area of ground-glass opacity in 2 different patients of COVID-19 pneumonia – air bubble sign (yellow arrows). These 
lucencies have an imperceptible wall, which differentiates them from a normal bronchus (red arrowhead)
A B
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Figure 13. Typical findings of dissipative stage of COVID-19 pneumonia on high-resolution computed tomography chest. A-B) A 47-year-old man with 
symptoms for 12 days. Axial (A) and coronal (B) chest computed tomography (CT) images show curvilinear fibrotic lines parallel to the chest wall in both 
lung fields (red arrowheads) with extensive reticulations in the upper lingula (red arrow) and traction bronchiectasis (blue arrow). Also note fibrotic strands 
with adjacent pleural thickening and bronchiectasis in the right upper lobe (yellow arrow) as a sequalae to prior tubercular infection. C) Axial CT chest 
image in a 42-year-old female shows curvilinear opacities parallel to the chest wall (red arrows) with adjacent reticulations. D) Similar findings are also 
seen in another patient in dissipative stage of the disease (red arrow). Also note associated traction bronchiectasis in the left upper lobe (yellow arrowhead)
A B
C D
Subpleural curvilinear lines and fibrosis: Fine curvi-
linear opacities paralleling the pleural surfaces are seen in 
COVID-19 pneumonia which is related to fibrosis. Other 
fibrotic stripes may result due to scarring from chronic 
inflammation. Some authors believe the appearance of fi-
brosis is a good prognostic sign in the disease, indicating 
stabilisation of the disease status [18,25]. However, it may 
progress to interstitial lung disease subsequently.
Patients in advanced or severe stages of the disease can 
progress to dissipation stage with residual fibrosis [25]. 
This temporal evolution is best evaluated on chest HRCT 
(Figure 14).
COVID-19 Reporting and Data System (CO-RADS) 
The “COVID-19 Standardised Reporting” working group 
of the Dutch Radiological Society has introduced CO-
RADS as a standardised HRCT chest-based assessment 
scheme for suspected COVID-19 patients in similar lines 
to the systems used for breast and lung malignancies [26]. 
CO-RADS measures the suspicion for COVID-19 pneumo-
nia using chest HRCT on a scale from 1 (very low probabil-
ity) to 5 (very high probability) as well as CO-RADS 0 for 
technically inappropriate studies and CO-RADS 6 for RT-
PCR-proven SARS CoV-2 infection. The CO-RADS cate-
gories with associated findings are summarised in Table 1, 
examples of which have been depicted in Figure 15.
Total Severity Score
Visual quantification of lung inflammation and correla-
tion with clinical severity of the disease were performed 
by Li et al. [27]. In their study, patients were classified into 
3 subgroups based on the clinical severity: mild (minimal-
ly symptomatic patients with normal CT), common, and 
severe-critical (patients with CT findings of COVID-19 
and varying clinical manifestations). A CT visual quanti-
tative score was devised by evaluating lung inflammation 
involving each lobe and summing up the scores of all five 
lobes. Each lobe was assessed for the percentage of lobar 
involvement: none (0%), minimal (1-25%), mild (26-
50%), moderate (51-75%), and severe (76-100%), which 
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Figure 14. Temporal changes in a 55-year-old man with COVID-19 pneumonia on chest high-resolution computed tomography. A) Axial computed tomog-
raphy (CT) chest images shows ground-glass opacities (GGOs) (red arrowhead) with interlobular septal thickening and formation of consolidations in both 
lung fields (red arrow). B) Follow-up chest CT performed after 1 month shows reduction in GGOs as compared to (A) with residual fibrosis (red arrows), 
suggesting progression to dissipation stage
Table 1. CO-RADS score
CO-RADS 
score
Chance of infection 
with COVID-19
CT findings Alternate diagnosis suspected
CO-RADS 0 Not interpretable Incomplete or inadequate quality scans due to breathing 
artefacts.
Scan technically insufficient, repeat study.
CO-RADS 1 Highly unlikely Normal CT scan, mild or severe emphysema, perifissural 
nodules, lung tumour, or fibrosis
Normal, non-infectious diseases like sarcoidosis, 
congestive heart failure, malignancy, interstitial 
lung disease to be considered.
CO-RADS 2 Unlikely A centrilobular nodular pattern (tree-in-bud sign), 
bronchiectasis, segmental consolidation, and lung 
cavitation.
Infective aetiology not compatible with 
COVID-19-like bronchitis, bronchiolitis, 
pneumonia, or lung abscess.
CO-RADS 3 Equivocal Perihilar GGO, extensive homogenous GGO, consolidation 
compatible with organising pneumonia.
CT features compatible with COVID-19 
pneumonia, but other diseases like organising 
pneumonia to be considered.
CO-RADS 4 Possible Findings similar to CO-RADS 5, but unilateral, not reaching 
the visceral pleura, predominantly peri-bronchovascular 
or superimposed on pre-existing abnormalities.
Highly suspicious for COVID-19.
CO-RADS 5 Highly likely GGO with or without consolidation close to visceral pleura; 
multifocal in distribution; sharply demarcated GGO with 
crazy-paving appearance, reverse halo sign, and vascular 
thickening 
CT features typical for COVID-19 infection.
CO-RADS 6 PCR proven – SARS CoV-2 positive on RT-PCR.
corresponded to scores of 0, 1, 2, 3, and 4, respectively. 
The score called the Total Severity Score (TSS) was ob-
tained by adding up the severity scores of all the 5 lobes 
(ranging from 0 to 20). TSS showed a significant differ-
ence between the common type and severe-critical type 
patients with a cut-off of 7.5 having a high sensitivity and 
specificity [27]. Calculation of TSS score in a prototype 
case are shown in Figure 16.
Association with pulmonary thromboembolism (Figure 17)
Thrombotic complications of COVID-19 infection caus-
ing significant morbidity and mortality have recently 
been recognised in published literature [28-30]. Various 
manifestations such as deep venous thrombosis, pulmo-
nary embolism, ischaemic stroke, and acute myocardial 
infarction have been reported. The pathophysiology has 
been ascribed to endothelial injury, inflammation, and 
microvascular thrombosis [30].
Atypical imaging features (Figure 18)
The presence of pulmonary nodules, mediastinal lym-
phadenopathy, and pleural effusions is rare in patients 
with COVID-19 [31]. At our institution, we have occa-
sionally come across COVID-19 patients with enlarged 
A B
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Figure 15. Representative axial high-resolution computed tomography (HRCT) chest images depicting CO-RADS. A) Normal HRCT chest: CO-RADS 1. 
B) Centrilobular nodules with tree-in-bud configuration in the right lung (red arrowheads) – bronchiolitis, later diagnosed as active pulmonary tuberculosis. 
CO-RADS 2. C) Dense consolidation with air bronchogram (red arrow) and surrounding ground-glass opacity (GGO) in a patient with Klebsiella pneumonia: 
CO-RADS 3. D) Peribronchovascular GGOs in the left lung (blue arrows): CO-RADS 4. Nasopharyngeal swab was positive for SARS-CoV-2. E) Peripheral and 
subpleural predominant multifocal GGOs with interlobular septal thickening – crazy-paving appearance (red arrows) in both lungs: CO-RADS 5. This was 
later proven to be COVID-19 pneumonia. F) Extensive, peripheral confluent bilateral GGOs with septal thickening in a patient with acute respiratory distress 




media stinal lymph nodes that could not be attributed to 
any other pathology (Figure 18A). A lymph node is clas-
sified as enlarged if it measures more than 10 mm in the 
short axis. Rare cases of COVID-19-positive patients with 
subsolid pulmonary nodules have also been observed 
(Figure 18C-D).
The typical mild COVID-19 pneumonia usually starts 
as a small subpleural, unilateral, or bilateral GGO in the 
lower lobes. This then develops into the crazy-paving 
pattern and subsequent consolidation, with an ARDS-
like imaging pattern in severe cases. The lesions gradually 
resolve with residual GGO and subpleural parenchymal 
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Figure 16. Total Severity Score (TSS) calculation in COVID-19 pneumonia using high-resolution computed tomography chest. Axial (A) and coronal (B) chest 
computed tomography (CT) images in a 42-year-old man with clinically severe COVID-19 pneumonia shows multifocal peripheral ground-glass opacities 
and consolidations in both lungs. Sagittal reformatted images of the right lung (C) and left lung (D) show less than 25% involvement of right middle lobe 







Figure 17. A 25-year-old man with COVID-19 pneumonia presenting with sudden onset breathlessness. A) Computed tomography (CT) pulmonary an-
giogram image shows an eccentric partial thrombus in the right descending pulmonary artery extending into the right middle lobe branch (red arrows). 
B) Axial CT image with lung window at the same level shows multifocal ground-glass opacities in both lung fields
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Figure 18. Atypical computed tomography (CT) chest findings in COVID-19 pneumonia. A) Axial chest CT image in a 32-year-old man in dissipative stage 
of disease shows an enlarged right paratracheal lymph node. B) Axial high-resolution computed tomography chest image in the same patient shows 
interlobular septal thickening with traction bronchiectasis and ground glass opacities suggestive of progression to interstitial lung disease. C-D) Axial chest 
CT images in 2 different patients with COVID-19 pneumonia show small subsolid nodules (red arrows)
bands over two weeks. This temporal evolution of the dis-
ease is illustrated in Figure 19.
Differential diagnosis
Viruses are an important cause of respiratory tract in-
fections, with overlapping clinical features and imaging 
findings. Although the imaging appearance of COVID-19 
is similar to that of other viruses like influenza, parain-
fluenza virus, and respiratory syncytial virus, significant 
differences do exist. Both human parainfluenza and in-
fluenza viruses show centrilobular nodules in addition 
to GGOs and consolidations [14]. Because severe acute 
respiratory syndrome (SARS) and MERS belong to the 
same coronavirus family, they share clinical features and 
imaging findings with COVID-19 pneumonia. Peripheral 
multifocal air space opacities are seen in all the 3 viral 
pneumonias; however, SARS has a greater incidence of 
focal unilateral involvement in the early course of disease, 
while both COVID-19 and MERS are predominantly bi-
lateral. MERS pneumonia has a higher incidence of pleu-
ral effusions and upper-lobe involvement as compared to 
COVID-19 pneumonias [32]. A final diagnosis is often 
made with laboratory analysis and virus isolation.
Conclusions
COVID-19 has affected every country throughout the 
world due to its contagious nature. Even though a large 
segment of the population has been affected, the fatality 
rate is higher in people with comorbidities. In the fight 
against this pandemic, radiologists play a crucial role in 
the rapid identification and early diagnosis of suspected 
patients. Thorough knowledge of the imaging features of 
COVID-19 pneumonia can allow for early containment 
and prompt response to help overcome this pandemic.
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Figure 19. Different stages of COVID-19 pneumonia on chest high-resolution computed tomography 
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